Your browser doesn't support javascript.
loading
Complete remission of refractory disseminated NK/T cell lymphoma with brentuximab vedotin and bendamustine.
Poon, Li-Mei; Kwong, Yok-Lam.
Affiliation
  • Poon LM; Department of Hematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore.
  • Kwong YL; Department of Medicine, Queen Mary Hospital, Professorial Block, Pokfulam Road, Hong Kong, China. ylkwong@hkucc.hku.hk.
Ann Hematol ; 95(5): 847-9, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26931114
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tumor Virus Infections / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Epstein-Barr Virus Infections / Lymphoma, Extranodal NK-T-Cell / Lymphoma, Primary Cutaneous Anaplastic Large Cell Limits: Adolescent / Female / Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Singapore Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Tumor Virus Infections / Antineoplastic Combined Chemotherapy Protocols / Salvage Therapy / Epstein-Barr Virus Infections / Lymphoma, Extranodal NK-T-Cell / Lymphoma, Primary Cutaneous Anaplastic Large Cell Limits: Adolescent / Female / Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2016 Document type: Article Affiliation country: Singapore Country of publication: Germany